Concateno makes first international buy
This article was originally published in Clinica
London, UK-based drug and alcohol testing business Concateno has announced its first international acquisition by agreeing to purchase Swedish company Marconova for £2m ($3.97m). The deal will see Concateno pay 50% in cash and the remainder in shares.
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.